NDC 50242-080 – Lucentis
Ranibizumab 10 mg/mL · Injection, Solution · Intravitreal
Product NDC50242-080
Product details
- Brand name
- Lucentis
- Generic name
- Ranibizumab
- Labeler
- Genentech, Inc.
- Dosage form
- Injection, Solution
- Route
- Intravitreal
- Marketing category
- BLA · BLA125156
- Marketed since
- June 30, 2006
- Listing expires
- December 31, 2026
- Pharmacologic class
- Vascular Endothelial Growth Factor Inhibitor
Active ingredients
- Ranibizumab 10 mg/mL
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 50242-080-03 | 1 SYRINGE, GLASS in 1 CARTON (50242-080-03) / .05 mL in 1 SYRINGE, GLASS | Oct 13, 2016 |
| 50242-080-88 sample | 1 SYRINGE, GLASS in 1 CARTON (50242-080-88) / .05 mL in 1 SYRINGE, GLASS | Oct 13, 2016 |
Other Lucentis products
- 50242-082 Ranibizumab 6 mg/mL · Injection, Solution · Genentech, Inc.